ESC 365
ESC 365
Sign in

    Back

    Time to say goodbye to aspirin in cardiovascular disease prevention? – the final word.

    26 August 2022 (14:40 - 15:15)
    Organised by:
    Congress Presentation Part of: Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention? Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

    Video

    Sign in for access options

    2 More presentations in this session

    Presentation thumbnail
    Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: pro.
    Doctor C. Aguiar (Lisbon, PT)
    Slides Video
    Presentation thumbnail
    Aspirin has a remaining role in the prevention and treatment of cardiovascular disease: con.
    Professor J. Cleland (Glasgow, GB)
    Slides Video

    Access the full session

    Session thumbnail
    Great Debate: time to say goodbye to aspirin in cardiovascular disease prevention?
    Video

    The Event

    Event poster

    ESC Congress 2022

    26 August 2022 14:40 CET
    You may be interested in
    thumbnail
    Webinar
    Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
    Logo
    thumbnail
    Congress Presentation
    Long-term aspirin adherence and risk of cardiovascular events and death after myocardial infarction: A nationwide cohort study
    Logo
    thumbnail
    Congress Presentation
    Is aspirin the preferred monotherapy after DAPT?
    Logo